Show Stocks and Investing Publications • Fri, May 5, 2023
Robert Burns Reiterated (ALLO) at Strong Buy and Held Target at $23 on, May 5th, 2023
rns-reiterated-allo-at-strong-buy-and-held-target-at-23-on-may-5th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024Robert Burns of HC Wainwright & Co., Reiterated "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $23 on, May 5th, 2023.
Robert has made no other calls on ALLO in the last 4 months.
There are 9 other peers that have a rating on ALLO. Out of the 9 peers that are also analyzing ALLO, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $7.5 on, Thursday, May 4th, 2023
- William Pickering of "Bernstein" Initiated at Hold and Held Target at $6 on, Tuesday, March 21st, 2023
- Benjamin Chaiken of "JMP Securities" Maintained at Hold with Decreased Target to $19 on, Thursday, March 2nd, 2023
These are the ratings of the 6 analyists that currently disagree with Robert
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $15 on, Thursday, May 4th, 2023
- Tony Butler of "EF Hutton" Maintained at Strong Buy and Held Target at $15 on, Monday, April 17th, 2023
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $31 on, Thursday, March 2nd, 2023
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $28 on, Wednesday, March 1st, 2023
- Brian Cheng of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $11 on, Tuesday, January 24th, 2023
- Jack Allen of "Baird" Upgraded from Hold to Buy and Held Target at $12 on, Friday, January 6th, 2023